U.S. Food Stock News

Allot (ALLT) is back in focus after reports that its Cybersecurity as a Service business delivered about 60% year over year growth in annual recurring revenue in the third quarter of 2025. See our latest analysis for Allot. That SECaaS momentum comes alongside a $10.86 share price, a 7 day share price return of 10.48% and a 1 year total shareholder return of 50.21%, hinting at building momentum despite a 5.57% 1 day pullback. If Allot’s recent move has caught your eye, it could be a good...

Independent Bank (INDB) is back on investors’ radar after a recent share price move, with the stock closing at $76.20. That has some investors reassessing its valuation and recent financial profile. See our latest analysis for Independent Bank. The recent 2.6% 1 day share price return and 4.3% 7 day share price return sit within a wider pattern that includes a 16.3% 90 day share price return and a 26.6% 1 year total shareholder return. This suggests momentum has been building over the medium...

ABM Industries (ABM) has elevated Melanie Kirkwood Ruiz to Executive Vice President and Chief Information Officer, and Tom Gallo to Executive Vice President and Chief Strategy Officer, spotlighting leadership around technology, acquisitions, and long term planning. See our latest analysis for ABM Industries. These leadership changes come as the share price sits at US$44.02, with a 7 day share price return of 4.07% and a 1 year total shareholder return decline of 12.19%, suggesting recent...

Recently, LandBridge reported its third-quarter 2025 results, completed the acquisition of 1918 Ranch projected to add about US$20,000,000 in EBITDA for fiscal 2026, and saw senior executives including the CFO and General Counsel increase their holdings through Class A share purchases. Alongside these moves, LandBridge’s subsidiary DBR Land Holdings LLC priced a US$500,000,000 senior notes offering and the company launched a 2,500,000-share Class A public offering, signaling active efforts...

Soleno Therapeutics recently reported that pivotal Phase 3 results for VYKAT XR in Prader-Willi syndrome were published in the Journal of Clinical Endocrinology and Metabolism, reinforcing the clinical basis for its FDA approval as the first treatment for hyperphagia in this population. The publication arrives amid short seller criticism of VYKAT XR’s safety and pricing, putting independently reviewed efficacy and safety data at the center of the debate. With these peer-reviewed Phase 3...

Capital Clean Energy Carriers Corp. recently took delivery of the Active, the world’s first 22,000 cbm low-pressure liquid CO2 carrier from Hyundai Mipo Dockyard, and immediately placed it on a time charter transporting LPG. The vessel’s ability to carry LCO2, LPG, ammonia and selected petrochemicals gives CCEC rare flexibility to serve both conventional gas trades and emerging carbon capture supply chains. Next, we’ll examine how this first-of-its-kind multi-cargo LCO2 carrier could...

CVR Partners (UAN) recently issued preliminary 2026 capital spending guidance of US$60 million to US$75 million, highlighting projects aimed at plant reliability, higher utilization, ammonia capacity expansion, feedstock flexibility, water quality, and diesel exhaust fluid production. See our latest analysis for CVR Partners. The capex announcement follows a period of strong momentum, with a 30 day share price return of 15.56% and a 1 year total shareholder return of 65.22%. Over 5 years, the...

Diversified Healthcare Trust (DHC) has set out a fresh course with three linked moves: large non core property sales, full repayment of its 2026 notes, and a broad reset of senior housing operations. See our latest analysis for Diversified Healthcare Trust. Those asset sales, debt repayment and senior housing changes arrive after a sharp shift in investor sentiment, with the share price at US$5.40 and a 90 day share price return of 33.33%, alongside a very large 3 year total shareholder...

Etsy (ETSY) is in focus after its board approved a new US$750 million share repurchase program and confirmed a leadership transition, with Kruti Patel Goyal stepping in as CEO along with new board responsibilities. See our latest analysis for Etsy. The leadership shift and new buyback program come after a mixed run for Etsy, with a 7-day share price return of 10.44% and a 30-day share price return of 11.02% contrasting with a 90-day share price decline of 10.91%. Over a longer horizon, the...

In early January 2026, Hormel Foods expanded its HORMEL® MARY KITCHEN® Hash lineup, rolling out two new protein-rich skillet products, Chorizo Skillet and Southwest Style Skillet, at select retailers across the US, aimed at quick, comforting meals for busy households. By emphasizing convenience, versatility across multiple meals, and bolder flavors, this launch highlights Hormel’s focus on higher-value, ready-to-heat options that can deepen brand engagement in the comfort-food...

Merit Medical Systems (MMSI) is in focus after the board appointed long time director F. Ann Millner as Chair, following Fred P. Lampropoulos’ resignation as director and Chair and his move into a short term consulting role. See our latest analysis for Merit Medical Systems. The leadership reshuffle comes as the 90 day share price return stands at 17.96% and the 30 day share price return at 11.74%. The 1 year total shareholder return of a 5.05% decline contrasts with 35.83% and 65.33% gains...

Howard Hughes Holdings (HHH) has drawn investor attention after recent share price moves, with the stock up 2.2% on the day and 3.2% over the past week, despite a small decline over the past month. See our latest analysis for Howard Hughes Holdings. Looking beyond the recent bounce, Howard Hughes Holdings has a 90 day share price return of 5.17% and a 1 year total shareholder return of 11.83%, suggesting momentum has been gradually building rather than fading. If this kind of move has you...

Oculis Holding (NasdaqGM:OCS) is back on investor radars after its neuroprotective candidate Privosegtor received FDA breakthrough therapy designation for optic neuritis, supported by Phase 2 ACUITY data and advancement into registrational PIONEER trials. See our latest analysis for Oculis Holding. The FDA breakthrough therapy news has arrived alongside a 10.3% 7 day share price return and a 10.2% year to date share price return, while the 1 year total shareholder return of 17.8% and very...

In recent months, American Bitcoin Corp. has rapidly expanded its Bitcoin holdings to 5,427 BTC, becoming the 19th-largest public corporate Bitcoin treasury while returning to a third-quarter net profit of US$3.47 million. Co-founder Eric Trump framed this disciplined accumulation drive, accelerated by December 2025 purchases of 1,064 BTC, as a focused effort to climb further up the global corporate Bitcoin holder rankings. We’ll now examine how American Bitcoin’s rapid Bitcoin treasury...

Aptar Digital Health, a division of AptarGroup, recently partnered with ŌURA to connect its Migraine Buddy app with the Oura Ring, while Ave Maria Growth Fund disclosed a new position in AptarGroup, highlighting its global dispensing technology franchise and long-term potential despite near-term challenges. Together, this digital health collaboration and endorsement from a growth-focused fund underscore how AptarGroup is extending its reach beyond physical drug delivery hardware into...

Why the latest nPulse study update matters for Pulse Biosciences (PLSE) Pulse Biosciences (PLSE) just flagged a fresh catalyst, with late-breaking 6- and 12-month data from its first-in-human nPulse Cardiac Catheter Ablation System study set for presentation at the 31st Annual AF Symposium 2026. See our latest analysis for Pulse Biosciences. The upcoming AF Symposium data drop lands after a mixed year for investors, with a 9.93% year to date share price return to US$14.72, a 16.36% 3 month...

Xometry, Inc. recently expanded its Instant Quoting Engine® with eight new high-performance additive manufacturing materials, added CNC control features including a "Preferred Subprocess" option and looser tolerance settings, and highlighted its attainment of CMMC Level 2 certification to better serve aerospace, defense, medical device, and automotive customers. By pairing advanced material capabilities with tighter security controls and more granular production choices, Xometry is...

In the third quarter of 2025, Enerpac Tool Group reported 6% year-over-year revenue growth, supported by strong regional performance and contributions from the acquired DTA business. The company also opened a new innovation lab and highlighted DTA’s expanding order backlog, which together underpin its product development and cross-selling ambitions. Next, we’ll examine how Enerpac’s innovation lab investment and DTA-driven growth influence its existing investment narrative and future...

Radware (RDWR) is back on investors' radar after unveiling ZombieAgent, a zero-click indirect prompt injection vulnerability affecting OpenAI's Deep Research agent, and announcing a doubling of its global cloud security mitigation capacity. See our latest analysis for Radware. These AI security headlines and the expansion of its cloud mitigation network come as Radware’s share price sits at US$24.06, with a 90 day share price return of a 7.5% decline but a 1 year total shareholder return of...

White Mountains Insurance Group recently completed a share repurchase of 64,064 shares for US$131.33 million and announced that its subsidiary Ark Insurance Holdings renewed its Outrigger Re Ltd. reinsurance sidecar for the 2026 underwriting year on terms similar to 2025, deploying US$70 million of third-party capital. The reduced size of Outrigger Re, alongside greater use of traditional quota share reinsurance, highlights an active recalibration of Ark’s capital and risk-transfer mix while...

Recently, Raymond James upgraded First Commonwealth Financial to Outperform, citing the bank’s strong capital position, resilient credit quality, and long-term growth prospects, while the company authorized a new US$25,000,000 share repurchase program and added a cybersecurity and regulatory compliance expert to its Board. This combination of an analyst upgrade, capital return initiative, and enhanced governance focus on cyber and compliance materially reshapes how investors may view First...

In early January 2026, LifeMD announced it is now offering Novo Nordisk’s newly FDA-approved Wegovy (semaglutide) pill through its nationwide telehealth platform, expanding virtual access to an oral GLP-1 option for chronic weight management and cardiovascular health at cash-pay prices starting from US$149 per month for eligible patients. This move deepens LifeMD’s collaboration with Novo Nordisk and positions the company more firmly in the fast-growing obesity care segment by pairing...

Why NCR Voyix Is On Investors’ Radar Today NCR Voyix (VYX) is drawing attention after recent trading left the shares at $10.76, with mixed return figures that include a 9.1% gain year to date and a 21.9% decline over the past year. See our latest analysis for NCR Voyix. The recent 1 month share price return of 11.39% at a last close of $10.76 contrasts with a 1 year total shareholder return decline of 21.97%, which suggests short term momentum is improving while longer term returns remain...

Why Calix Stock Is Back on Investors’ Radar Calix (CALX) has recently attracted attention after a stretch of mixed share performance, with a 1 day return of negative 2.24% and a negative move over the past month and past 3 months. See our latest analysis for Calix. The recent 1 month share price return of 7.49% and 3 month share price return of 10.79% sit against a 1 year total shareholder return of 34.92% and a 5 year total shareholder return of 57.11%. This suggests momentum has cooled in...